Chronic systemic inflammation (e.g., IL-6, TNF-α–driven pathways) promotes proteolysis and metabolic derangements, and sarcopenia has been linked to dysregulated immune cell function and reduced antitumor immunity. This evidence concerns the gene TNF and sarcopenia.